NSPR InspireMD, Inc.
Price Chart
Executive Summary
Four InspireMD insiders, including CEO Marvin Slosman and three directors, collectively purchased $227K in open-market shares over a one-week period following the company's Q1 2026 earnings release. The buys represent ~0.43% of market cap and signal management's confidence despite a voluntary recall of CGuard Prime 135 cm and a net loss of $13.7M.
Key Financial Metrics
Actionable Insight
Insider cluster buying post-earnings suggests the recall is viewed as manageable and the 122% revenue growth trajectory is intact. Monitor for FDA approval of original CGuard delivery system (expected Q3 2026) and resolution of the 135 cm recall — both could serve as catalysts. The CEO's personal purchase alongside directors reinforces bullish conviction.
Key Facts
- 4 insiders purchased $227K in open-market shares (May 6–13, 2026)
- CEO Marvin Slosman bought 21,000 shares at $1.20 ($25K)
- Director Gary S. Roubin bought 90,000 shares at $1.18 ($106K)
- Director Scott R. Ward bought 73,300 shares at $1.15 ($84K)
- Director Paul Stuka bought 10,000 shares at $1.16 ($12K)
- Cluster follows Q1 2026 earnings: revenue $3.4M (+122% YoY), net loss $13.7M ($0.16/share)
- Voluntary recall of CGuard Prime 135 cm delivery system reserved $1.35M in costs
Financial Impact
$227K insider purchases (0.43% of $53M market cap)
Risk Factors
- Voluntary recall of CGuard Prime 135 cm may dampen near-term U.S. sales
- Net loss widening to $13.7M in Q1 2026 from $11.2M a year ago
- Small market cap ($53M) amplifies stock volatility
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NSPR-1778875774219 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 21, 2026
19d ago
|
Insider Cluster
| $1.00 $0.9900 | ▼ −1.00% | ▼ −2.66% | $0.7654 (−23.46%) |
|
May 15, 2026
25d ago
|
Insider Cluster
| $1.05 $0.9500 | ▼ −9.52% | ▼ −11.14% | $0.7654 (−27.10%) |
|
May 7, 2026
4w ago
|
Insider Cluster
| $1.16 $1.17 | ▲ +0.86% | ▼ −0.64% | $0.7654 (−34.02%) |
|
May 1, 2026
5w ago
|
8-K
| $1.17 $1.25 | ▼ −6.84% | ▼ −3.90% | $0.7654 (+34.58%) |
|
May 1, 2026
5w ago
|
Press Release
| $1.17 $1.25 | ▼ −6.84% | ▼ −3.90% | $0.7654 (+34.58%) |
|
May 1, 2026
5w ago
|
Press Release
| $1.17 $1.25 | ▲ +6.84% | ▲ +3.90% | $0.7654 (−34.58%) |
|
Apr 22, 2026
6w ago
|
DEFA14A
| $1.28 $1.14 | ▼ −10.94% | ▼ −12.42% | $0.7654 (−40.20%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.33 $1.14 | ▼ −14.29% | ▼ −15.37% | $0.7654 (−42.45%) |
|
Apr 3, 2026
9w ago
|
424B5
| $1.49 $1.35 | ▲ +9.40% | ▲ +13.53% | $0.7654 (+48.63%) |
|
Mar 18, 2026
11w ago
|
8-K
| $1.79 $1.77 | ▼ −1.12% | ▼ −0.40% | $0.7654 (−57.24%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access